Jooyoung Park
- جديد
- 18سنة خبره ١٦ سنة
- كوريا الجنوبية, سول, BIOFACE Clinic
Dr. Joo-young Park, MD
Chief Medical Director & CEO, BIOFACE Clinic
Professional Profile
Board-certified dermatologist and anti-aging specialist with over a decade of clinical and research leadership. Dr. Park combines expertise in laser systems, injectable aesthetics, thread-lift techniques, and regenerative therapies to deliver evidence-based protocols that prioritize patient safety, comfort, and natural, lasting outcomes. A sought-after educator and consultant, he has trained hundreds of clinicians and guided protocol development for leading medical device and biotech firms.
Education & Training
Dermatology Residency, Seoul National University Hospital
Advanced training in laser therapies, injectables, and anti-aging proceduresMedical Student Summer Program, Samsung Medical Center (Sungkyunkwan Univ.)
KSKCS Non-invasive Cosmetic Surgery Course
KCCS Asian Lipoplasty Workshop
Professional Experience
Founder, CEO & Medical Director, BioFace Clinic (2018–Present)
Lead all clinical operations, research initiatives, and strategic growth both domestically and internationally.QOFill Filler Educator, JW Pharmaceutical (2016–Present)
Deliver hands-on workshops on safe, precise filler injection techniques to over 300 physicians nationwide.HIFU Lifting Technology Consultant (2017–Present)
Advise device manufacturers on protocol optimization to maximize lift efficacy while minimizing downtime.Clinical Advisor, L&C BIO (KOSDAQ-listed) (2019–Present)
Design and analyze clinical trials for novel dermatologic injectables.Clinical Advisor, UTI (Application Specialist)
Provide scientific support and training for UTI’s aesthetic device portfolio.Technical Consultant, NewThera
Guide R&D and protocol development for next-generation aesthetic injectables.Invited Lectures & Publications
Invited Speaker, Medical Asia 2016
“Next-Generation Filler Strategies” presented to 500+ regional aesthetic practitioners.Key Publication:
Kim JW, Li MH, Jang JH, et al.
15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂ rescues PC12 cells from H₂O₂-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1: potential roles of Akt and ERK1/2.
Biochem Pharmacol. 2008;76(11):1577–1589.Academic & Professional Memberships
Korean Academy of Laser Medicine
World Society for Laser Medicine & Surgery
Korean Society for Hair Research
Korean Society of Anti-Aging Dermatology
Korean Society of Obesity & Aesthetic Treatment
Korean Society of Obesity & Body Shaping
Korean Society for Stem Cell Therapy
Korean Society of Primary Care
Select Achievements
Developed research-driven, multi-modal anti-aging protocols integrating lasers, injectables, thread lifts, and stem-cell boosters.
Trained 300+ physicians in advanced filler and HIFU applications, elevating national standards of care.
Received the Korean Society of Aesthetic Medicine’s Excellence in Education Award.
Served as medical advisor on KBS health documentary series and multiple international media features.
Core Competencies
Evidence-Based Protocols: Continuous refinement through outcome analysis of thousands of patient cases
Integrated Anti-Aging: Holistic treatment plans tailored for minimal discomfort and rapid recovery
Educational Leadership: Curriculum design and delivery for clinician workshops and medical symposia
Strategic Consulting: Product development guidance for device manufacturers and biotech firms
Languages & Continuing Education
Languages: Korean (native), English (fluent)
Continuing Education: Regular faculty at international conferences; numerous peer-reviewed publications in leading dermatology journals.
- اقرأ المزيد